By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A Nasdaq panel has granted Pressure BioSciences' request for continued listing on the exchange, the company said today.

The Nasdaq Listing Qualifications Panel told Pressure Bio of its decision on Dec. 7 to allow the company to remain listed on the Nasdaq Capital Market until Feb. 29, 2012, subject to certain conditions, including the company's demonstration of compliance with a listing requirement to have at least $2.5 million in stockholder equity.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.